Queer researchers are exploring how treatments for meningitis and malaria could be used “off-label” to prevent gonorrhoea, syphilis and chlamydia.
According to Canadian queer magazine Xtra, there are three ongoing trials, all helmed by queer scientists, looking at the antibiotic doxycycline and how it could be used to prevent sexually transmitted and blood borne infections (STBBIs) like syphilis and chlamydia.
Daily doxycycline pills are usually prescribed to prevent malaria, although it has other approved uses like treating severe acne and infections.
Darrell Tan, an infectious diseases specialist who leads one of the studies, said: “In addition to being a gay man, I wear my hat as a researcher. From that researcher’s perspective, most of us don’t feel like it’s quite ready for prime time yet.”
This article was written by Lily Wakefield and originally posted on Pink News. Please click HERE to read the full article.